Saturday, March 19, 2005

A new setback for gene therapy

href="http://seattletimes.nwsource.com/html/businesstechnology/
2002211498_tgen18.html" target=_blank>Fifteen years ago, researchers
thought cystic fibrosis would be the first easy hit of the gene-therapy
revolution. The deadly lung disease is caused by a single faulty gene,
so, in theory, delivering a properly functioning one into cells ought
to cure the disease.
It may happen someday, but yesterday one of
the stalwarts of the cystic-fibrosis field, Seattle-based Targeted
Genetics, dropped out. In the largest clinical trial ever conducted of
gene therapy for cystic fibrosis, with 102 patients, the company failed
to reach its goal of helping patients breathe significantly better,
even for a month

posted by ryan griffis  # 1:48 PM

Comments: Post a Comment



Links to this post:

Create a Link



<< Home

Archives

June 2004   July 2004   August 2004   September 2004   October 2004   November 2004   December 2004   January 2005   February 2005   March 2005   April 2005   May 2005   June 2005   July 2005   August 2005   September 2005   October 2005   November 2005   December 2005   January 2006   February 2006   March 2006   April 2006   May 2006   June 2006   July 2006   August 2006   September 2006   October 2006   November 2006   December 2006   January 2007   February 2007   March 2007   April 2007   May 2007   June 2007   July 2007  

syndicate [atom]

preBlog archives

This page is powered by Blogger. Isn't yours?